4.7 Article

Inhibitory Interactions between BK and JC Virus among Kidney Transplant Recipients

Journal

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 22, Issue 5, Pages 825-831

Publisher

AMER SOC NEPHROLOGY
DOI: 10.1681/ASN.2010080877

Keywords

-

Funding

  1. NIH [2 K24-02886, DK 079333]

Ask authors/readers for more resources

BK and JC polyomaviruses can reactivate after transplantation, causing renal dysfunction and graft loss. The incidence of JC reactivation after renal transplant is not well understood. Here, we characterized JC reactivation using samples collected during the first year after transplantation from 200 kidney recipients. We detected BK and JC viruses in the urine of 35 and 16% of transplant recipients, respectively. The median viral load in the urine was 400 times higher for BK virus than JC virus. The presence of BK viruria made concurrent JC viruria less likely: JC viruria was detected in 22% of non-BK viruric recipients compared with 4% of BK viruric recipients (P = 0.001). The co-detection rate was 1.5%, which is less than the expected 5.6% if reactivation of each virus was independent (P = 0.001). We did not observe JC viremia, JC nephropathy, or progressive multifocal leukoencephalopathy. The onset of JC viruria was associated with donor, but not recipient, JC-specific antibody in a titer-dependent fashion and inversely associated with donor and recipient BK-specific antibody. Donor and recipient JC seropositivity did not predict BK viruria or viremia. In conclusion, among renal transplant recipients, infection with one polyomavirus inversely associates with infection with the other.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Toward telemedicine-compatible physical functioning assessments in kidney transplant candidates

Daniel J. Watford, Xingxing S. Cheng, Jialin Han, Margaret R. Stedman, Glenn M. Chertow, Jane C. Tan

Summary: This study found that self-reported SF-36 physical functioning subscale score can predict the risk faced by kidney transplant candidates, especially the risk of waitlist removal or death. These metrics can be obtained remotely and help identify patients with poor physical functioning.

CLINICAL TRANSPLANTATION (2021)

Review Cardiac & Cardiovascular Systems

Coronary Computed Tomography Angiography in Diagnosing Obstructive Coronary Artery Disease in Patients with Advanced Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Xingxing S. Cheng, Suman Mohanty, Valery Turner, Domenico Mastrodicasa, Simon Winther, Dominik Fleischmann, Jane C. Tan, William F. Fearon

Summary: This study conducted a systematic review and meta-analysis on the sensitivity and specificity of CCTA in patients with advanced kidney disease, showing that CCTA has high sensitivity but lower specificity compared to non-kidney disease population.

CARDIORENAL MEDICINE (2021)

Article Surgery

Consensus conference on heart-kidney transplantation

Jon Kobashigawa, Darshana M. Dadhania, Maryjane Farr, W. H. Wilson Tang, Arvind Bhimaraj, Lawrence Czer, Shelley Hall, Abdolreza Haririan, Richard N. Formica, Jignesh Patel, Rafael Skorka, Savitri Fedson, Titte Srinivas, Jeffrey Testani, Julie M. Yabu, Xingxing S. Cheng

Summary: Simultaneous heart-kidney transplant has achieved successful outcomes for patients with end-stage heart disease and concomitant kidney disease, but decision-making for this procedure presents challenges. A consensus conference in 2019 aimed to develop interdisciplinary criteria, evaluate kidney allocation, and recommend standardized care for sHK recipients.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Letter Surgery

Incorporating kidney-related multi-organ transplants into the kidney allocation sequence

Xingxing S. Cheng, Peter P. Reese

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Surgery

The organ procurement costs of expanding deceased donor organ acceptance criteria: Evidence from a cost function model

Xingxing S. Cheng, Philip J. Held, Avi Dor, Jennifer L. Bragg-Gresham, Jane C. Tan, John D. Scandling, Glenn M. Chertow, John P. Roberts

Summary: Expanding donor acceptability criteria to include nonstandard donors could be a potential solution to the organ shortage issue. Despite higher costs per organ, kidney transplantation from nonstandard donors remained cost-effective based on contemporary US data, with economies of scale observed in high OPO volume leading to lower costs.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Gastroenterology & Hepatology

Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome

Allison Kwong, W. Ray Kim, Paul Y. Kwo, Uerica Wang, Xingxing Cheng

Summary: In non-ICU settings where terlipressin is not available, a sequential vasoconstrictor regimen of midodrine-octreotide followed by norepinephrine can be effective in improving transplant-free survival and achieving responses for patients with hepatorenal syndrome (HRS).

LIVER TRANSPLANTATION (2021)

Article Surgery

Optimal patient selection for simultaneous heart-kidney transplant: A modified cost-effectiveness analysis

Brian Wayda, Xingxing S. Cheng, Jeremy D. Goldhaber-Fiebert, Kiran K. Khush

Summary: The increasing rates of simultaneous heart-kidney (SHK) transplant in the United States exacerbate the shortage of deceased donor kidneys (DDK). The current allocation policy does not impose constraints on SHK eligibility. By applying a decision-analytic model, this study compares SHK with a Safety Net strategy and identifies patient subsets for whom SHK is efficient. The findings favor the implementation of a Safety Net provision and the establishment of objective criteria for SHK transplant eligibility.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Surgery

Center variations in patient selection for simultaneous heart-kidney transplantation

Brian Shaw, Marya L. Samoylova, Andrew S. Barbas, Xingxing S. Cheng, Yee Lu, Lisa M. McElroy, Scott Sanoff

Summary: There are no established regulations governing patient selection for simultaneous heart-kidney transplantation, leading to significant variations in clinical practice among different centers. National guidelines are needed to standardize the selection of patients for SHK.

CLINICAL TRANSPLANTATION (2022)

Article Medicine, General & Internal

Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017

Xingxing S. Cheng, Jialin Han, Jennifer L. Braggs-Gresham, Philip J. Held, Stephan Busque, John P. Roberts, Jane C. Tan, John D. Scandling, Glenn M. Chertow, Avi Dor

Summary: This study aims to describe the temporal trends in Organ Acquisition Cost Center (OACC) costs per kidney transplantation and identify the factors associated with cost. The study found that OACC costs increased by 4% per year from 2012 to 2017 and were not solely attributable to the cost of organ procurement. Expanding the waiting list is likely to contribute to further increases in OACC costs and substantially increase Medicare liability.

JAMA NETWORK OPEN (2022)

Article Cardiac & Cardiovascular Systems

Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association: Endorsed by the American Society of Transplantation

Xingxing S. Cheng, Lisa B. VanWagner, Salvatore P. Costa, David A. Axelrod, Sripal Bangalore, Silas P. Norman, Charles A. Herzog, Krista L. Lentine

Summary: Coronary heart disease is a significant cause of mortality and morbidity in kidney and liver transplantation candidates and recipients. Screening for asymptomatic candidates has not shown to improve outcomes but is common in practice. New approaches and multidisciplinary involvement are suggested for pretransplant evaluation.

CIRCULATION (2022)

Article Medicine, General & Internal

Association of Pretransplant Coronary Heart Disease Testing With Early Kidney Transplant Outcomes

Xingxing S. Cheng, Sai Liu, Jialin Han, Margaret R. Stedman, Michael Baiocchi, Jane C. Tan, Glenn M. Chertow, William F. Fearon

Summary: Testing for coronary heart disease (CHD) before kidney transplant is common, but its association with perioperative outcomes is unclear. This cohort study found that pretransplant CHD testing was not associated with a reduction in early posttransplant death or acute MI.

JAMA INTERNAL MEDICINE (2023)

Article Urology & Nephrology

Kidney Stone Events after Kidney Transplant in the United States

Calyani Ganesan, Malorie Holmes, Sai Liu, Maria Montez-Rath, Simon Conti, Timothy C. C. Chang, Colin R. Lenihan, Xingxing S. S. Cheng, Glenn M. Chertow, John T. Leppert, Alan C. C. Pao

Summary: Background: Kidney stone disease is common and can lead to complications in kidney transplant recipients. This study found that approximately 2% of kidney transplant recipients were diagnosed with a kidney stone in the first 3 years after transplantation. Risk factors for kidney stone events included a history of kidney stones and longer dialysis vintage.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Gastroenterology & Hepatology

One size does not fit all: Differential benefits of simultaneous liver-kidney transplantation by eligibility criteria

Xingxing S. Cheng, Lisa M. Mcelroy, Scott L. Sanoff, Allison J. Kwong

Summary: Standard eligibility criteria for simultaneous liver-kidney transplantation (SLK) are established in the US. This study examines the mortality benefit of SLK compared to liver transplant alone, based on the specific SLK eligibility criteria met by the patients. The analysis of a retrospective cohort of liver transplant or SLK recipients indicates that SLK is associated with a survival benefit, particularly for patients with end-stage kidney disease.

LIVER TRANSPLANTATION (2023)

Letter Medicine, General & Internal

In Reply

Xingxing S. S. Cheng

JAMA INTERNAL MEDICINE (2023)

Article Urology & Nephrology

Trends in Coronary Artery Disease Screening before Kidney Transplantation

Xingxing S. Cheng, Sai Liu, Jialin Han, Margaret R. Stedman, Glenn M. Chertow, Jane C. Tan, William F. Fearon

Summary: Coronary artery disease (CAD) screening rates before kidney transplantation in the United States remained constant from 2000 through 2015, despite widespread changes in cardiology guidelines and practice.

KIDNEY360 (2022)

No Data Available